Does diclofenac increase or decrease blood pressure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diclofenac Increases Blood Pressure

Diclofenac causes an increase in blood pressure and should be avoided or withdrawn in patients with hypertension, particularly those with resistant hypertension. 1, 2

Mechanism and Clinical Evidence

NSAIDs, including diclofenac, interfere with blood pressure control through inhibition of renal prostaglandin synthesis, leading to sodium and water retention 2. The FDA drug label explicitly warns that diclofenac can lead to new onset of hypertension or worsening of preexisting hypertension 2.

Magnitude of Blood Pressure Elevation

The blood pressure increase with diclofenac is clinically significant:

  • In hypertensive patients, diclofenac raised systolic BP by 8.5 mmHg and diastolic BP by 2.4 mmHg over 2 weeks 3
  • In the MEDAL study, diclofenac was associated with statistically significant BP increases, though etoricoxib showed even greater effects 4
  • Diclofenac caused virtually complete COX-2 inhibition over the entire dosing interval, corresponding to the highest increase in systolic BP among NSAIDs studied 5
  • In ACE inhibitor-treated patients, diclofenac increased 24-hour systolic BP by 4.1 mmHg and reduced GFR by 9.9 mL/min 6

Comparative Risk Among NSAIDs

Diclofenac carries particularly high cardiovascular risk among NSAIDs 7, 8, 9. A Danish registry study found diclofenac was associated with a hazard ratio of 2.40 (95% CI 2.09-2.80) for death in post-MI patients 7. The AHA scientific statement concluded that cardiovascular risk is proportional to COX-2 selectivity, and diclofenac—despite being classified as "non-selective"—has strong COX-2 inhibitory properties 8, 9.

Clinical Management Recommendations

For Patients with Hypertension

NSAIDs, particularly diclofenac, should be avoided or withdrawn in patients with resistant hypertension 1. When clinically unavoidable:

  • Use the lowest effective dose for the shortest possible time 7, 2
  • Monitor blood pressure closely during initiation and throughout treatment 1, 2
  • Recognize that adjustments to antihypertensive regimens may become necessary 1

Preferred Alternatives

If analgesics are necessary, acetaminophen may be preferable to NSAIDs in subjects with resistant hypertension, though it provides little anti-inflammatory benefit 1. For musculoskeletal pain in cardiovascular disease patients, consider topical agents (lidocaine, diclofenac, capsaicin) or less-sedating muscle relaxants 10.

Drug Interactions

Diclofenac may blunt the effects of antihypertensive medications, including:

  • ACE inhibitors and ARBs 2
  • Thiazide and loop diuretics 2
  • Beta-blockers 2

Calcium channel blockers appear to maintain antihypertensive effects better than other drug classes when used concurrently with NSAIDs 4.

Additional Cardiovascular Concerns

Beyond blood pressure elevation, diclofenac increases risk of:

  • Heart failure hospitalization (approximately 2-fold increase) 2
  • Myocardial infarction and cardiovascular death 7, 8
  • Fluid retention and edema 2

Common Pitfalls

  • Assuming "non-selective" NSAIDs like diclofenac are safer than COX-2 inhibitors—diclofenac has strong COX-2 selectivity and comparable or greater cardiovascular risk 8, 5, 9
  • Failing to monitor BP when initiating diclofenac in patients on stable antihypertensive regimens
  • Overlooking over-the-counter NSAID use when evaluating resistant hypertension 1

References

Research

The effect of etoricoxib versus diclofenac on blood pressure in hypertensive patients.

JPMA. The Journal of the Pakistan Medical Association.., 2021

Research

Cardiovascular effects and safety of (non-aspirin) NSAIDs.

Nature reviews. Cardiology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.